Chugai Pharmaceutical Co., Ltd. (CHGCY)
OTCMKTS · Delayed Price · Currency is USD
29.33
-0.10 (-0.34%)
Feb 10, 2026, 10:34 AM EST

Revenue

Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Domestic Oncology Revenue
246.50B247.70B
Domestic Oncology Revenue Growth
-0.48%-4.80%
Domestic Specialty Revenue
225.80B213.40B
Domestic Specialty Revenue Growth
5.81%-28.34%
Total Domestic Revenue
472.40B461.10B
Total Domestic Revenue Growth
2.45%-17.37%
Overseas Revenue
605.40B536.80B
Overseas Revenue Growth
12.78%28.88%
Product Sales
1.08T997.90B
Product Sales Growth
8.01%2.40%
Royalties and Other Operating Income
180.10B172.70B
Royalties and Other Operating Income Growth
4.29%26.15%
Updated Dec 31, 2025. Data Source: Fiscal.ai.